Myelin basic protein binding cells in active multiple sclerosis

Arthur Vandenbark, J. V. Hallum, R. L. Swank, A. Tong, D. R. Burger

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A sensitive, antigen-specific rosetting technique was used to enumerate blood cells that bind myelin basic protein (BP) in MS patients and controls. Sixteen of 23 MS patients in exacerbation but only 7 of 48 in remission formed elevated numbers of rosettes. Five of the latter 7 patients had recovered from an exacerbation within four months of the laboratory evaluation. Eight of 20 patients with progressive MS, all of whom had had disease for more than four years, had BP rosette-forming cells. None of the 16 normal volunteers and 1 of 8 neurological controls had BP rosette-forming cells. These results suggest that BP-binding cells in MS are confined to patients in acute exacerbation or within four months of activity, and those who have had progressive disease for at least four years.

Original languageEnglish (US)
Pages (from-to)8-12
Number of pages5
JournalAnnals of Neurology
Volume6
Issue number1
DOIs
StatePublished - 1979

Fingerprint

Myelin Basic Protein
Protein Binding
Multiple Sclerosis
Blood Cells
Healthy Volunteers
Proteins
Antigens

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Myelin basic protein binding cells in active multiple sclerosis. / Vandenbark, Arthur; Hallum, J. V.; Swank, R. L.; Tong, A.; Burger, D. R.

In: Annals of Neurology, Vol. 6, No. 1, 1979, p. 8-12.

Research output: Contribution to journalArticle

Vandenbark, Arthur ; Hallum, J. V. ; Swank, R. L. ; Tong, A. ; Burger, D. R. / Myelin basic protein binding cells in active multiple sclerosis. In: Annals of Neurology. 1979 ; Vol. 6, No. 1. pp. 8-12.
@article{13a3c7066348471b889ae3a032a301cd,
title = "Myelin basic protein binding cells in active multiple sclerosis",
abstract = "A sensitive, antigen-specific rosetting technique was used to enumerate blood cells that bind myelin basic protein (BP) in MS patients and controls. Sixteen of 23 MS patients in exacerbation but only 7 of 48 in remission formed elevated numbers of rosettes. Five of the latter 7 patients had recovered from an exacerbation within four months of the laboratory evaluation. Eight of 20 patients with progressive MS, all of whom had had disease for more than four years, had BP rosette-forming cells. None of the 16 normal volunteers and 1 of 8 neurological controls had BP rosette-forming cells. These results suggest that BP-binding cells in MS are confined to patients in acute exacerbation or within four months of activity, and those who have had progressive disease for at least four years.",
author = "Arthur Vandenbark and Hallum, {J. V.} and Swank, {R. L.} and A. Tong and Burger, {D. R.}",
year = "1979",
doi = "10.1002/ana.410060103",
language = "English (US)",
volume = "6",
pages = "8--12",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Myelin basic protein binding cells in active multiple sclerosis

AU - Vandenbark, Arthur

AU - Hallum, J. V.

AU - Swank, R. L.

AU - Tong, A.

AU - Burger, D. R.

PY - 1979

Y1 - 1979

N2 - A sensitive, antigen-specific rosetting technique was used to enumerate blood cells that bind myelin basic protein (BP) in MS patients and controls. Sixteen of 23 MS patients in exacerbation but only 7 of 48 in remission formed elevated numbers of rosettes. Five of the latter 7 patients had recovered from an exacerbation within four months of the laboratory evaluation. Eight of 20 patients with progressive MS, all of whom had had disease for more than four years, had BP rosette-forming cells. None of the 16 normal volunteers and 1 of 8 neurological controls had BP rosette-forming cells. These results suggest that BP-binding cells in MS are confined to patients in acute exacerbation or within four months of activity, and those who have had progressive disease for at least four years.

AB - A sensitive, antigen-specific rosetting technique was used to enumerate blood cells that bind myelin basic protein (BP) in MS patients and controls. Sixteen of 23 MS patients in exacerbation but only 7 of 48 in remission formed elevated numbers of rosettes. Five of the latter 7 patients had recovered from an exacerbation within four months of the laboratory evaluation. Eight of 20 patients with progressive MS, all of whom had had disease for more than four years, had BP rosette-forming cells. None of the 16 normal volunteers and 1 of 8 neurological controls had BP rosette-forming cells. These results suggest that BP-binding cells in MS are confined to patients in acute exacerbation or within four months of activity, and those who have had progressive disease for at least four years.

UR - http://www.scopus.com/inward/record.url?scp=0018389448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018389448&partnerID=8YFLogxK

U2 - 10.1002/ana.410060103

DO - 10.1002/ana.410060103

M3 - Article

C2 - 92212

AN - SCOPUS:0018389448

VL - 6

SP - 8

EP - 12

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -